Shinpoong Pharmaceutical Co., Ltd. (019170.KS) KSC

Currency In KRW

AD

Valuation

Market Cap774.8B
Enterprise Value783.22B
P/E Ratio-982.2
PEG Ratio7.25
Price/Sales Ratio2.03
Price/Book Ratio1.82
Enterprise/Revenue2.05
Enterprise/EBITDA33.65

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0
Operating Margin0.01
AD

Management Effectiveness

Return On Assets-0
Return On Equity-0

Income Statement

Revenue234.68B
Revenue/Share4,451.9
Gross Profit102.37B
EBITDA25.65B
Net Income8.83B
Diluted EPS172

Balance Sheet

Total Cash72.3B
Total Cash/Share1,346.32
Total Debt53.28B
Total Debt/Equity0.19
Current Ratio2.86
Book Value Per Share5,177.62

Price History

52-Week Change-28.07
52-Week High15,900
52-Week Low6,310
Moving Average 50 Days8,977.8
Moving Average 200 Days10,636.5

Statistics

Average Volume367,860
Shares Outstanding51.71M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor26:25
Last Split DateDecember 29, 2014
AD